Akt1-IN-8
Akt1-IN-8 (Compound JL18) is a potent and oral bioavailable (41%) inhibitor of AKT1 kinase, with an IC50 of 8.8 nM. Akt1-IN-8 exhibits significant antiproliferative effects against PC-3 prostate cancer cells, with an IC50 of 3.0 μM. Akt1-IN-8 can reduce phosphorylated GSK3β levels.
For research use only. We do not sell to patients.
- CAS No.: 2247688-87-3
- Formula: C21H25Br2N7O
- Molecular Weight:551.28
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
|
Akt1 8.8 nM (IC50) |
Chemical Information
-
CAS No. 2247688-87-3
-
Molecular Weight 551.28
-
Formula C21H25Br2N7O
-
SMILES
O=C(C(CNC(C)C)C1=CC=C(C=C1)Br)N2CCN(CC2)C3=C4C(Br)=NNC4=NC=N3
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)